Related Experiment Videos
Recurrent minimal change disease post-allograft renal transplant
1Department of Pathology, Tri-Service General Hospital, Cheng-Kung Road Sec, 2 No. 325, Taipei, Taiwan, R.O.C. 114. janc1206@ms65.hinet.net
Transplantation Proceedings
|December 31, 2003
Summary
This case study reports the first instance of recurrent minimal change disease (MCD) after a kidney transplant in a young adult. Despite transplantation, the patient experienced disease recurrence, highlighting challenges in managing steroid-resistant MCD.
Area of Science:
- Nephrology
- Transplantation Immunology
- Renal Pathology
Background:
- Minimal change disease (MCD) is a primary cause of nephrotic syndrome, often responsive to steroids.
- Steroid-resistant MCD presents a therapeutic challenge, with limited treatment options and potential for progression.
- Kidney transplantation is a treatment option for end-stage renal disease, but recurrence of primary glomerular diseases is a known complication.
Observation:
- A young adult with biopsy-confirmed steroid-resistant MCD, without evidence of FSGS, underwent kidney transplantation.
- Post-transplant, the patient developed recurrent nephrotic syndrome and renal insufficiency, despite aggressive management.
- Histopathological examination of the explanted graft confirmed MCD morphology, ruling out FSGS.
Findings:
- The patient experienced recurrence of minimal change disease in the allograft shortly after transplantation.
- Despite treatment, graft function did not improve, necessitating graft nephrectomy.
- This represents the first documented case of recurrent MCD following kidney transplantation.
Implications:
- Recurrence of MCD post-transplant can lead to graft failure and presents a significant clinical challenge.
- Further research is needed to understand the mechanisms of MCD recurrence and develop effective preventative or therapeutic strategies.
- This case underscores the importance of careful diagnosis and consideration of potential recurrence in transplant candidates with MCD.